相关实验视频
Updated: Jun 30, 2025
11:14
Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging
Published on: April 6, 2014
12.4K
COVID-19神经成像更新:病理生理学,急性发现和后急性发展
Andrew C McClelland1, Steven J Benitez2, Judah Burns2
1Department of Radiology, NYU Grossman School of Medicine, New York, NY.
Seminars in ultrasound, CT, and MR
|March 22, 2024
概括
本综述涵盖了COVID-19中神经成像发现,详细介绍了早期流行病的出现和神经系统效应的演变. 它探讨了病理生理学,包括细胞因子风暴和免疫反应,并讨论了长期COVID成像.
科学领域:
- 神经学 神经学
- 放射学 放射学是一门学科.
- 传染性疾病 传染性疾病
背景情况:
- COVID-19显著影响神经系统,神经成像揭示了关键表现.
- 早期的流行病观察集中在急性COVID-19的神经效应上.
研究的目的:
- 审查急性COVID-19的神经成像外观.
- 突出神经系统影响和成像发现背后的病理生理学.
- 讨论神经成像在整个大流行期间的演变作用,包括长期COVID.
主要方法:
- 关于与COVID-19相关的神经成像研究的文献综述.
- 分析病理生理学,包括细胞因子风暴,凝血病和免疫媒介现象.
- 讨论COVID-19急性和后急性阶段的神经成像发现.
主要成果:
- 神经成像揭示了COVID-19患者的神经系统的各种影响.
- 病理生理机制包括全身炎症,凝血病和免疫反应.
- 影像检测结果随着大流行,疫苗开发和长期COVID的出现而演变.
结论:
- 神经成像对于了解COVID-19的神经影响至关重要.
- 病理生理学解释了观察到的神经成像异常.
- 成像在监测COVID-19神经系统后续,包括长期COVID中发挥着至关重要的作用.
更多相关视频
12:07A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation
Published on: September 19, 2010
23.7K
08:25Intravital Imaging of Fluorescent Protein Expression in Mice with a Closed-Skull Traumatic Brain Injury and Cranial Window Using a Two-Photon Microscope
Published on: April 21, 2023
1.1K
相关概念视频
01:14Brain Imaging
228
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
228
01:26Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469